Founded in 1998, Zhejiang Xianju Junye Pharmaceutical Co., Ltd. is a high-tech enterprise with activities in steroid hormone APIs & intermediates, developing, manufacturing and marketing in domestic and overseas markets. Located at Xianju County, Taizhou City, Zhejiang Province, Junye covers an area of 102,000 m2, with 52,000 m2 of floor area and a registered fund of USD 8.01million. Near 500 employees, among which, bachelor degree or above (includes doctor & master) covers 20.21% and technical college degree covers 49.75%. In 2011, Junye achieved sales of CNY 350 million. Moreover, in 2012, exceeding sales of CNY 450 million will be expected.The main products of Junye are steroid hormone APIs (e.g. sex hormones, progestational hormones and cortical hormones) & intermediates. And Junye possesses the leading technology at home and abroad. The production scale of tibolone intermediate and mifepristone is the largest in China, and occupy 70% of market share in these fields. Our product, mifepristone, has passed the GMP & COS, and has filed US FDA at present. Another product, norethiserone, has also passed COS. Junye's sales network spreads across Asia, Europe, America and South America, and it is the preferred supplier of top 500 pharmaceutical enterprises over the world.

Junye plays an active part in Industry-Academy-Research cooperation, and establishes three joint laboratories with Chinese Academy of Science, Zhejiang University and East China Normal University. Besides, a team of various kinds of technical experts is formed, which is in charge of the development of green production process in steroidal compounds and the application of combing biochemical technology with organic synthetic technology.

Junye has successively taken responsibilities for the projects of China Torch Program, China Creative Funds and National New Product Plan, and has taken part in the R&D and trail production of the key projects of Zhejiang province green chemical industry. Moreover, Junye has successively taken 7 National Major Projects and has taken part in the R&D of over 20 major projects of Zhejiang province. Besides, Junye has applied 3 patents, and achieved total 27 projects on commercialization of research findings.In 2011, from the perspective of strategic development, Junye invested and established a new production base, Jiangxi Junye Bio-Pharmaceutical Co., Ltd., located at Wannian Industry Zone, Jiangxi Province. It covers an area of 333,333 m2, with an investment of CNY500 million, expected to be completed and go into operation in 2013.

The construction of Jiangxi Junye Bio-Pharmaceutical Co., Ltd. marks the formation of capital expansion strategy developing the new and high-tech pharmaceutical products, bio-pharmaceutical as core product. Junye is now stepping forward her“age of large professional pharmaceutical group”.